Accordingly, PPARγ activation gave rise to inhibition of proliferation of 9 bladder cancer cell lines [31] All in all, the SNHG1/miR-9-3p/MDM2/PPARγ axis was involved in bladder cancer progression. This evidence concerns the gene PPARG and urinary bladder carcinoma.